Clinical Trial Update: Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris [Phase 1]

View source ↗

Summary

A Phase 1 trial assesses the antipsoriatic effect of a Circassia topical formulation for psoriasis vulgaris; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Circassia topical formulation

Snippet

Sponsor: Circassia Limited | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED